Matches in Nanopublications for { ?s ?p "[However vemurafenib, a type I mutant BRAF V600 inhibitor, induces an array of proliferative skin disorders from keratosis pilaris-like and keratoacanthoma-like lesions to locally aggressive cutaneous squamous cell carcinoma (cuSCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1216529.RAu5ep1ynLFdzJbzsccRtIMg8BHufUSDG3u9gC9wCVYWI130_assertion description "[However vemurafenib, a type I mutant BRAF V600 inhibitor, induces an array of proliferative skin disorders from keratosis pilaris-like and keratoacanthoma-like lesions to locally aggressive cutaneous squamous cell carcinoma (cuSCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216529.RAu5ep1ynLFdzJbzsccRtIMg8BHufUSDG3u9gC9wCVYWI130_provenance.
- NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_assertion description "[However vemurafenib, a type I mutant BRAF V600 inhibitor, induces an array of proliferative skin disorders from keratosis pilaris-like and keratoacanthoma-like lesions to locally aggressive cutaneous squamous cell carcinoma (cuSCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.